LONDON - EMV Capital Plc, a company listed on the London Stock Exchange (LON:LSEG), has disclosed a change in its major shareholdings, as required by the UK's Financial Conduct Authority. The notification, which follows the standard TR-1 form, details a decrease in the stake held by Dr. Ilian P Iliev and Futura Messis Group Limited.
On January 3, 2025, the threshold for reporting was crossed when the combined voting rights attached to shares and financial instruments held by Dr. Iliev and the Futura Messis Group Limited fell to 13.91% of EMV Capital's total voting rights, down from the previously reported 14.11%. The total number of voting rights now held by these entities is 3,861,457.
The notification also outlined the distribution of voting rights between direct and indirect holdings. Directly, Dr. Iliev holds 0.95%, while Futura Messis Group Limited holds 12.96%. No financial instruments with similar economic effects were reported.
Additionally, the notification included details of EMV Capital share options, which could potentially be exercised or converted into voting rights in the future. These share options, with expiration dates ranging from September 24, 2030, to December 30, 2034, represent a potential additional 2.47% of voting rights, or 685,656 shares.
The notification did not specify any single event as the cause for the change in holdings but indicated that the threshold was crossed on January 3, 2025, with the company being notified on the same day.
This disclosure is part of the regulatory requirements that ensure transparency in the financial markets, allowing investors to be aware of significant changes in share ownership. It is based on a press release statement from EMV Capital Plc and is intended to provide investors with the latest information on the shareholding structure of the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.